share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Mar 19 16:41
Summary by Moomoo AI
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 20,054 Class A shares on 03/19/2024, as per the latest filing. These shares, initially acquired on 09/01/2016 as founders shares, were part of Borgeson's compensation from the issuer. The sale is expected to yield an aggregate market value of approximately $216,423. Borgeson's transaction history over the past three months includes the sale of 111,717 shares, generating total gross proceeds of around $1,293,849. The upcoming sale follows a series of transactions by Borgeson, with the most recent sale occurring on 03/05/2024.
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 20,054 Class A shares on 03/19/2024, as per the latest filing. These shares, initially acquired on 09/01/2016 as founders shares, were part of Borgeson's compensation from the issuer. The sale is expected to yield an aggregate market value of approximately $216,423. Borgeson's transaction history over the past three months includes the sale of 111,717 shares, generating total gross proceeds of around $1,293,849. The upcoming sale follows a series of transactions by Borgeson, with the most recent sale occurring on 03/05/2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more